Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

A quantitative coronary angiography-matched comparison between a prospective randomised multicentre cutting balloon angioplasty and bare metal stent trial (REDUCE III) and the Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESEARCH) study.

Ozaki Y, Lemos PA, Yamaguchi T, Suzuki T, Nakamura M, Ismail TF, Kitayama M, Nishikawa H, Kato O, Serruys PW.

EuroIntervention. 2010 Aug;6(3):400-6. doi: 10.4244/EIJV6I3A66.

PMID:
20884421
2.

Impact of cutting balloon angioplasty (CBA) prior to bare metal stenting on restenosis.

Ozaki Y, Yamaguchi T, Suzuki T, Nakamura M, Kitayama M, Nishikawa H, Inoue T, Hara K, Usuba F, Sakurada M, Awano K, Matsuo H, Ishiwata S, Yasukawa T, Ismail TF, Hishida H, Kato O.

Circ J. 2007 Jan;71(1):1-8.

3.

Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.

Fischer D, Scheller B, Schäfer A, Klein G, Böhm M, Clever Y, Cremers B.

EuroIntervention. 2012 Aug;8(4):450-5. doi: 10.4244/EIJV8I4A71.

4.

Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study.

Rodriguez AE, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Rodriguez Granillo AM, Rodriguez-Granillo GA, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios IF, Serruys PW; ORAR III Investigators.

EuroIntervention. 2009 Jun;5(2):255-64.

PMID:
20449934
5.

The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.

Roy P, Steinberg DH, Sushinsky SJ, Okabe T, Pinto Slottow TL, Kaneshige K, Xue Z, Satler LF, Kent KM, Suddath WO, Pichard AD, Weissman NJ, Lindsay J, Waksman R.

Eur Heart J. 2008 Aug;29(15):1851-7. doi: 10.1093/eurheartj/ehn249. Epub 2008 Jun 11.

PMID:
18550555
6.

Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials.

Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW.

JACC Cardiovasc Interv. 2009 Dec;2(12):1269-75. doi: 10.1016/j.jcin.2009.10.005.

7.

Clinical Effectiveness and Cost Effectiveness of Intracoronary Brachytherapy and Drug Eluting Stents [Internet].

Mørland B, Kløw NE, Rotevatn S, Steigen T, Vatne K, Wisløff T, Kristiansen IS, Norderhaug I.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2004.

8.

Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.

Berta B, Jambrik Z, Kohar K, Szabo G, Ruzsa Z, Molnar L, Barczi G, Geller L, Becker D, Merkely B.

Hellenic J Cardiol. 2014 Sep-Oct;55(5):369-77.

9.

Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.

Ando H, Amano T, Takashima H, Harada K, Kitagawa K, Suzuki A, Kunimura A, Shimbo Y, Harada K, Yoshida T, Kato B, Uetani T, Kato M, Matsubara T, Kumagai S, Yoshikawa D, Isobe S, Ishii H, Murohara T.

Eur Heart J Cardiovasc Imaging. 2013 Oct;14(10):996-1001. doi: 10.1093/ehjci/jet003. Epub 2013 Jan 22.

PMID:
23341147
10.

A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.

Habara S, Iwabuchi M, Inoue N, Nakamura S, Asano R, Nanto S, Hayashi Y, Shiode N, Saito S, Ikari Y, Kimura T, Hosokawa J, Nakamura M, Kotani J, Kozuma K, Mitsudo K.

Am Heart J. 2013 Sep;166(3):527-33. doi: 10.1016/j.ahj.2013.07.002. Epub 2013 Aug 13.

PMID:
24016503
11.

The impact of IVUS guided bare metal stent implantation for non-small vessel.

Kataoka T, Shimada K, Fukuda D, Nishioka H, Oda S, Ehara S, Hirose M, Kamimori K, Kobayashi Y, Yoshiyama M, Takeuchi K, Yoshikawa J.

Osaka City Med J. 2004 Dec;50(2):79-86.

PMID:
15819302
12.

Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J.

Circulation. 2012 Jun 12;125(23):2873-91. doi: 10.1161/CIRCULATIONAHA.112.097014. Epub 2012 May 14.

14.

The unrestricted use of sirolimus- and paclitaxel-eluting stents results in better clinical outcomes during 6-year follow-up than bare-metal stents: an analysis of the RESEARCH (Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated At Rotterdam Cardiology Hospital) registries.

Simsek C, Magro M, Boersma E, Onuma Y, Nauta ST, Gaspersz MP, van der Giessen WJ, van Domburg RT, Serruys PW; Interventional Cardiologists of the Thoraxcenter.

JACC Cardiovasc Interv. 2010 Oct;3(10):1051-8. doi: 10.1016/j.jcin.2010.08.003.

15.

[Compare drug-eluting stent to bare-metal stent in prognosis on treating diffuse coronary lesions].

Qiao SB, Hou Q, Xu B, Chen J, Liu HB, Yang YJ, Wu YJ, Yuan JQ, Wu Y, Dai J, You SJ, Ma WH, Zhang P, Gao Z, Dou KF, Qiu H, Mu CW, Chen JL, Gao RL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Jun;34(6):487-91. Chinese.

PMID:
16842660
16.

Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(12):1-97. Epub 2006 Apr 1.

17.

A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.

Rathore S, Kinoshita Y, Terashima M, Katoh O, Matsuo H, Tanaka N, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura K, Asakura Y, Suzuki T.

EuroIntervention. 2010 Feb;5(7):841-6.

PMID:
20142201
18.

Impairment factors for evaluating the patency of drug-eluting stents and bare metal stents in coronary arteries by 64-slice computed tomography versus conventional coronary angiography.

Nakamura K, Funabashi N, Uehara M, Suzuki K, Terao M, Okubo K, Mita Y, Maeda F, Komuro I.

Int J Cardiol. 2008 Nov 28;130(3):349-56. doi: 10.1016/j.ijcard.2007.08.104. Epub 2008 Jan 3.

PMID:
18180050
19.

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.

Habara S, Kadota K, Shimada T, Ohya M, Amano H, Izawa Y, Kubo S, Hyodo Y, Otsuru S, Hasegawa D, Tada T, Tanaka H, Fuku Y, Goto T, Mitsudo K.

J Am Coll Cardiol. 2015 Jul 7;66(1):14-22. doi: 10.1016/j.jacc.2015.05.002.

20.

Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions.

Assali A, Raz Y, Vaknin-Assa H, Ben-Dor I, Brosh D, Teplitsky I, Fuchs S, Kornowski R.

EuroIntervention. 2008 May;4(1):108-14.

PMID:
19112787

Supplemental Content

Support Center